Practical Pharmacology for Alzheimer’s Disease - Takashi Kudo, Kenneth L. Davis, Rafael Blesa Gonzalez, David George Wilkinson

Practical Pharmacology for Alzheimer’s Disease

Buch | Softcover
VIII, 141 Seiten
2018 | 1. Softcover reprint of the original 1st ed. 2016
Springer International Publishing (Verlag)
978-3-319-79906-3 (ISBN)
139,09 inkl. MwSt

In this book, the four leading experts on the ACE inhibitors donepezil, galantamine, and rivastigmine and the NMDA receptor antagonist memantine explain the practical pharmacology of these symptomatic drugs with the aim of providing a sound basis for their clinical use in patients with Alzheimer's disease. In addition, an introductory chapter considers the basic theory of pharmacology for Alzheimer's disease and the book closes with an overview of the ways in which symptomatic drugs for dementia are used.

The wide acceptance of the amyloid cascade hypothesis has led to vigorous development of disease-modifying drugs for Alzheimer's disease, such as amyloid vaccinations and gamma- or beta-secretase inhibitors. The failure of clinical trials of these drugs to yield satisfactory results has, however, meant that for the time being patients continue to be treated only with symptomatic drugs. There is accordingly a need to become more proficient in the use of symptomatic medicines, and it is against the background of this quest that Practical Pharmacology for Alzheimer's Disease will be of wide interest.

Dr. Takashi Kudo, Osaka University Health Care Center, Department of Psychiatry,Toyonaka, JapanDr. Kenneth Davis, Mount Sinai Medical Center, New York, NY 10029, USADr. Rafael Blesa Gonzalez, Autonomous University of Barcelona, Barcelona, SpainDr. David George Wilkinson, University of Southampton, Southampton, United Kingdom

Basic theory of pharmacology for Alzheimer's disease.- Practical Pharmacology of Donepezil.- Practical pharmacology of Galantamine.- Practical pharmacology of Rivastigmine.- Practical Pharmacology of Memantine.- How do we use Symptomatic drugs for Dementia.

"Written by four experts in dementia research, this book describes the pharmacology of the four symptomatic drugs used in the treatment of Alzheimer's disease. It provides an overview of the basic theories of the pharmacology of Alzheimer's disease and the way in which the medications are used for the treatment of dementia. ... book is most suitable for geriatric psychiatrists, geriatric medicine specialists, and neurologists who spend a significant amount of time treating people with Alzheimer's disease and other dementias." (Danielle L. Anderson, Doody's Book Reviews, June, 2016)

Erscheint lt. Verlag 30.3.2018
Zusatzinfo VIII, 141 p. 27 illus., 18 illus. in color.
Verlagsort Cham
Sprache englisch
Maße 155 x 235 mm
Gewicht 329 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Neurologie
Medizin / Pharmazie Medizinische Fachgebiete Pharmakologie / Pharmakotherapie
Medizin / Pharmazie Medizinische Fachgebiete Psychiatrie / Psychotherapie
Medizin / Pharmazie Pharmazie
Schlagworte Alzheimer • Alzheimer's disease • Donepezil • Galantamine • pharmacotherapy • Psychopharmacology • Rivastigmine • Symptomatic Drugs
ISBN-10 3-319-79906-1 / 3319799061
ISBN-13 978-3-319-79906-3 / 9783319799063
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
interdisziplinäre Diagnose- und Behandlungsstrategien

von Christoph Maier; Ulrike Bingel; Esther Pogatzki-Zahn

Buch | Hardcover (2024)
Urban & Fischer in Elsevier (Verlag)
97,00